Objectives: To estimate average annual cost per multiple sclerosis (MS) patient in the US
using published estimates from the literature. Methods: A search was performed of English …

Strength training has, in recent years, been shown to be beneficial for people with Parkinson
disease and multiple sclerosis. Consensus regarding its utility for these disorders …

Objective: To examine the pricing trajectories in the United States of disease-modifying
therapies (DMT) for multiple sclerosis (MS) over the last 20 years and assess the influences …

Multiple sclerosis (MS) is a chronic demyelinating condition characterized by plaques in the
white matter of the central nervous system that can be detected using magnetic resonance …

Multiple sclerosis (MS) is a disabling, chronic disease that imposes a significant economic
burden on patients and the US healthcare system. The largest cost component for …

Impact of Diagnosis and Early Treatment on the Course of Multiple Sclerosis Page 1 VOL. 19, NO.
17 ■ THE AMERICAN JOURNAL OF MANAGED CARE ■ S321 Multiple sclerosis (MS), a …

Background Multiple sclerosis (MS) is a chronic progressive condition affecting the central
nervous system. Progression of MS results in increased level of disability and most patients …

Background In 2002, the UK's National Institute for Clinical Excellence (NICE) concluded
that interferon beta and glatiramer acetate would be cost effective as disease-modifying …

Multiple sclerosis (MS) is disease that has an early age of onset and may intensify and
subside with disease relapses or exacerbations interrupted by periods of stability. Because …

Reports from more than 600 hematopoietic stem cell transplants (HSCT) have appeared in
the medical literature for the last 1 and one-half decades. The patient's own stem cells are …